Delivery Order SPE2DB20D1050-SPE2DB23FH96L
Award Date 9/5/23
Potential Completion Date 9/6/23
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Troop Support Medical awarded a $3,247.98 firm fixed price delivery order to Amerisourcebergen Drug Corp for the purchase of 4562457478 XCOPRI 100 MG TABLET 30S. The place of performance is Conshohocken, Pennsylvania, with an expected completion date of October 13, 2023. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, which will serve as the prime contractor. No set-aside designation was used for this order. The Defense Logistics Agency...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $5,655 to Amerisourcebergen Drug Corporation for the supply of 4562162136 XCOPRI 200 MG TABLET 30S. The prime contractor, Amerisourcebergen Drug Corporation, is headquartered in Conshohocken, Pennsylvania and will fulfill the order from its corporate office division located at that address. Funding is provided by the Defense Logistics Agency to support its medical supply needs. Performance is...
- The Defense Logistics Agency awarded a $2,869.08 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 150 mg XCOPRI tablets. The prime contractor, Amerisourcebergen Drug Corporation, is headquartered in Conshohocken, Pennsylvania and will fulfill the order from its facility located at the same address. The delivery order was issued on July 12, 2023 under the DLA's Pharmaceutical Prime Vendor contract to provide pharmaceuticals and medical supplies in support of...
- The Defense Logistics Agency awarded a delivery order valued at $3,219.60 to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-count units) with an ultimate completion date of August 28, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor headquartered in Conshohocken, Pennsylvania. The contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $1,813 delivery order to Amerisourcebergen Drug Corporation for 30 tablets of the 200 mg XCOPRI medication. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DOD components. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a four-day period concluding on September 19, 2023. The firm fixed price order was awarded competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of XCOPRI 50 MG tablets (30-count packages) valued at $7,622.85. This firm fixed-price delivery order represents a non-competitive award and carries an ultimate completion date of August 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of XCOPRI 100 MG TABLET 30S. The order, valued at $3,247.98, has a completion date of February 12, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, primarily through indefinite...
- The Defense Logistics Agency awarded a $2,432.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XCOPRI 150 mg tablets (30-count units) with a completion date of August 4, 2025. This non-set-aside contract represents a competitively awarded pharmaceutical supply transaction executed on August 1, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $3,536.88 to AmerisourceBergen Drug Corp for XCOPRI 200 mg tablets (30-count units) under a firm fixed price contract. The award was made on July 30, 2025, with a completion date of July 31, 2025, and performance will be executed at the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designation, reflecting the vendor's established capability to meet federal...
- The Defense Logistics Agency Troop Support Medical awarded a $875.17 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for the supply of 150mg XCOPRI tablets. The prime contractor will deliver 30 tablets to a location in Conshohocken, Pennsylvania by August 17, 2023 to fulfill the requirements of this contract issued under an unspecified government-wide acquisition contract vehicle. No set-aside designation or subcontractors were identified. The Defense...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB23FH96LDelivery Order
The Defense Logistics Agency awarded a $1,537.06 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562053593 XCOPRI 100 MG TABLET 30S. The prime contractor, Amerisourcebergen Drug Corporation, is headquartered in Conshohocken, Pennsylvania and will fulfill the order from their facility located at the same address. Funding is provided by the Defense Logistics Agency to support their procurement of pharmaceutical products. The delivery order has a period of performance from September 5, 2023 through September 6, 2023. No set aside designation or subcontracting requirements were specified.
Generated 12/22/23, 3:16 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/5/23 |